Proposal aims to build a database of bulk drug traders, improve traceability of imported raw materials, over 70% of which ...

The move would dismantle the existing system under which bulk drugs and finished formulations operate under a common licence ...

Antique expects the Concord to report revenue, Ebitda and PAT CAGR of 18 per cent, 17 per cent and 19 per cent, respectively, ...

UP govt to discuss Lalitpur bulk drugs park with pharma companies in Telangana on Jan 6: Shardul Nautiyal, Mumbai Tuesday, January 6, 2026, 08:00 Hrs [IST] To boost self-reliance ...

Antique said it expected Concord Biotech to deliver revenue, Ebitda and PAT CAGR of 18 per cent, 17 per cent and 19 per cent, ...

NPPA to allow Serum Institute to discontinue manufacturing of two pack sizes of TT vaccine: Gireesh Babu, New Delhi Monday, December 29, 2025, 08:00 Hrs [IST] The National Pharmac ...

APIs are a key ingredient for making different kinds of medicines in the country. And yet, nearly 65-70% of supplies of APIs in the country are still imported from China. The government has encouraged ...

The MIP, if approved, may potentially enable domestic capacity to survive the price onslaught of Chinese suppliers and will also make Aurobindo Pharma's investment under India’s Production-Linked ...

Shilpa Medicare has received an ex-parte ad-interim injunction order from the Delhi High Court, restraining the company and ...

The global Temperature Controlled Package for Pharmaceutical market revenue was USD 4215 Million in 2022 and is forecast to a readjusted size of USD 9343.6 Million by 2029 with a CAGR of 11.9% during ...

The agenda of the CEOs’ roundtable includes discussions on issues involving captains of industry, industrial trade bodies and ...